National Institutes of Health consensus development conference statement: oral complications of cancer therapies: diagnosis, prevention, and treatment.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D009059:Mouth Diseases / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D009316:National Institutes of Health (U.S.); D011878:Radiotherapy / Q000009:adverse effects*; D014481:United States
D000970:Antineoplastic Agents